Stock DURATA THERAPEUTICS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Durata Therapeutics Inc Stock

Equities

US26658A1079

Biotechnology & Medical Research

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Durata Therapeutics Inc
2014 Wall St. falls in choppy day; traders wary before earnings RE

Latest news about Durata Therapeutics Inc

Wall St. falls in choppy day; traders wary before earnings RE
More news

Press releases Durata Therapeutics Inc

Durata Therapeutics : Actavis Receives FDA Approval for VIBERZI (eluxadoline) for the Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults PU
Durata Therapeutics : Infectious Disease Experts, Scientists and Clinicians Join Forces on SHARE ID™ to Accelerate the Battle Against Antibiotic-resistant Infections PU
Durata Therapeutics : Actavis Confirms Generic Letairis® Patent Challenge PU
Durata Therapeutics : Actavis Announces Michael R. Gallagher and Peter J. McDonnell to Join Board of Directors PU
Durata Therapeutics : Actavis and Allergan Shareholders Approve Proposals Related to Actavis' Planned Acquisition of Allergan PU
More press releases

Company Profile

More about the company

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.92% 42.59B
MODERNA, INC. Stock Moderna, Inc.
+8.45% 40.65B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 40.57B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.77B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.99% 24.81B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-24.33% 18.17B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+28.89% 12.05B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-2.86% 11.7B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+7.26% 11.1B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. Stock